Source: ChristianToday Published May 1, 2008 @ 11:50pm PDT
An appeals court on Thursday ruled the countrys healthcare costeffectiveness watchdog had acted unfairly in the way it decided to curb access to Alzheimers drugs in a victory for drugmakers and patients [full article]
Comments for this article are printed below.
Crossmap is not responsible for comments that appear below this notice.
